Simulations Plus Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Shawn O'Connor

İcra Kurulu Başkanı

US$1.1m

Toplam tazminat

CEO maaş yüzdesi	47.85%
CEO görev süresi	1yr
CEO sahipliği	n/a
Yönetim ortalama görev süresi	1yr
Yönetim Kurulu ortalama görev süresi	4.8yrs

Son yönetim güncellemeleri

Recent updates

Simulations Plus: Solid Platform, Soft Outlook (Rating Upgrade)

Dec 09

Simulations Plus, Inc. (NASDAQ:SLP) Shares Could Be 44% Below Their Intrinsic Value Estimate

Oct 28

Some Simulations Plus, Inc. (NASDAQ:SLP) Shareholders Look For Exit As Shares Take 25% Pounding

Jul 31

Simulations Plus, Inc.'s (NASDAQ:SLP) Stock Retreats 36% But Earnings Haven't Escaped The Attention Of Investors

Jun 13

Are Investors Undervaluing Simulations Plus, Inc. (NASDAQ:SLP) By 28%?

May 07

Simulations Plus: Benefiting From FDA Modernization And AI

Apr 16

Simulations Plus, Inc.'s (NASDAQ:SLP) 25% Jump Shows Its Popularity With Investors

Apr 13

Why Investors Shouldn't Be Surprised By Simulations Plus, Inc.'s (NASDAQ:SLP) 29% Share Price Surge

Feb 08

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Jan 08

We Think Simulations Plus' (NASDAQ:SLP) Healthy Earnings Might Be Conservative

Nov 07

Biosimulation Innovations And Tactical Acquisitions To Boost Drug Development Growth

Oct 27 Integration and expansion into new markets drive revenue growth and improved profitability through increased efficiencies and enhanced offerings.

Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI

Feb 01

We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

Jan 12

CEO Tazminat Analizi

Shawn O'Connor'un ücretlendirmesi Simulations Plus'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Aug 31 2025	US$1m	US$525k	-US$65m
May 31 2025	n/a	n/a	-US$63m
Feb 28 2025	n/a	n/a	US$7m
Nov 30 2024	n/a	n/a	US$8m
Aug 31 2024	US$2m	US$512k	US$10m
May 31 2024	n/a	n/a	US$10m
Feb 29 2024	n/a	n/a	US$11m
Nov 30 2023	n/a	n/a	US$11m
Aug 31 2023	US$2m	US$487k	US$10m
May 31 2023	n/a	n/a	US$10m
Feb 28 2023	n/a	n/a	US$10m
Nov 30 2022	n/a	n/a	US$11m
Aug 31 2022	US$1m	US$450k	US$12m
May 31 2022	n/a	n/a	US$12m
Feb 28 2022	n/a	n/a	US$12m
Nov 30 2021	n/a	n/a	US$10m
Aug 31 2021	US$1m	US$444k	US$10m
May 31 2021	n/a	n/a	US$12m
Feb 28 2021	n/a	n/a	US$11m
Nov 30 2020	n/a	n/a	US$10m
Aug 31 2020	US$739k	US$350k	US$9m
May 31 2020	n/a	n/a	US$9m
Feb 29 2020	n/a	n/a	US$9m
Nov 30 2019	n/a	n/a	US$9m
Aug 31 2019	US$425k	US$325k	US$9m

Tazminat ve Piyasa: Shawn 'nin toplam tazminatı ($USD 1.10M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 2.32M ).

Tazminat ve Kazançlar: Shawn 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Shawn O'Connor (65 yo)

1yr

Görev süresi

US$1,096,572

Tazminat

Mr. Shawn M. O'Connor serves as Chief Executive Officer of Simulations Plus, Inc. since 2025 and had been Chief Executive Officer since June 26, 2018 until 2025. Mr. O'Connor joined Simulations Plus, Inc....

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Shawn O'Connor	Chief Executive Officer	1yr	US$1.10m	Veri yok
William Frederick	CFO, Executive VP & Corporate Secretary	5.1yrs	US$534.65k	0.010% $ 38.0k
Josh Fohey	Chief Operating Officer	less than a year	US$358.27k	Veri yok
John DiBella	Chief Revenue Officer	less than a year	US$488.97k	0.40% $ 1.4m
Jill Fiedler-Kelly	President of Services Solutions	no data	US$465.08k	0.34% $ 1.2m
Steven Chang	Global Head of Strategic Alliances	less than a year	US$482.28k	0% $ 0
Jennifer Presnell	Accounting Manager	no data	Veri yok	Veri yok
Viera Lukacova	Chief Science Officer	5.3yrs	Veri yok	Veri yok
Bud Nelson	VP of Corporate Counsel & Personal Data Protection Officer	no data	Veri yok	Veri yok
Christina Hendrickson	Senior Director of Corporate Marketing	no data	Veri yok	Veri yok
Lindsay Luke	Vice President of Human Resources	4yrs	Veri yok	Veri yok
Scott Siler	Chief Science Officer of Quantitative Systems Pharmacology	1yr	Veri yok	Veri yok

1.0yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: SLP 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Walter Woltosz	Director	29.6yrs	US$155.27k	16.28% $ 59.4m
Daniel Weiner	Independent Chairman of the Board	8.7yrs	US$193.52k	0.063% $ 229.2k
Ravindra Mehta	Member of Scientific Advisory Board	4.8yrs	Veri yok	Veri yok
Paul Watkins	Chairman of Scientific Advisory Board	4.8yrs	Veri yok	Veri yok
John Paglia	Independent Director	11.1yrs	US$180.02k	0.053% $ 193.7k
Frank Sistare	Member of Scientific Advisory Board	4.8yrs	Veri yok	Veri yok
Lauren Aleksunes	Member of Scientific Advisory Board	4.8yrs	Veri yok	Veri yok
K. Hallow	Member of Scientific Advisory Board	4.8yrs	Veri yok	Veri yok
Sharlene Evans	Independent Director	4.1yrs	US$175.52k	0.066% $ 240.5k

4.8yrs

Ortalama Görev Süresi

67.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SLP 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.8 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2026/01/04 18:26
Gün Sonu Hisse Fiyatı	2026/01/02 00:00
Kazançlar	2025/08/31
Yıllık Kazançlar	2025/08/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Simulations Plus, Inc. 11 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
David Larsen	BTIG
Dane Leone	CGS International
Constantine Davides	Citizens JMP Securities, LLC

Simulations Plus Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Simulations Plus, Inc., Annual General Meeting, Feb 12, 2026

Director notifies of intention to sell stock

Director notifies of intention to sell stock

Insufficient new directors

Simulations Plus, Inc., Annual General Meeting, Feb 13, 2025

Simulations Plus, Inc. Announces Executive Changes, Effective August 30, 2024

Recent updates

Simulations Plus, Inc., Annual General Meeting, Feb 12, 2026

Simulations Plus, Inc. to Report Q1, 2026 Results on Jan 08, 2026

Simulations Plus: Solid Platform, Soft Outlook (Rating Upgrade)

Full year 2025 earnings: EPS misses analyst expectations

Simulations Plus, Inc. Reaffirms Revenue Guidance for Fiscal 2026

Simulations Plus, Inc. (NASDAQ:SLP) Shares Could Be 44% Below Their Intrinsic Value Estimate

Simulations Plus, Inc. to Report Q4, 2025 Results on Dec 01, 2025

Director notifies of intention to sell stock

Some Simulations Plus, Inc. (NASDAQ:SLP) Shareholders Look For Exit As Shares Take 25% Pounding

Simulations Plus, Inc. and Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor Models with Enhanced AI Drug Design

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Simulations Plus, Inc. Updates Earnings Guidance for the Fiscal Year 2025

Consensus EPS estimates fall by 16%

Director notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 33%

Consensus EPS estimates fall by 20%

Simulations Plus, Inc.'s (NASDAQ:SLP) Stock Retreats 36% But Earnings Haven't Escaped The Attention Of Investors

New minor risk - Share price stability

Now 34% undervalued after recent price drop

Simulations Plus, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of Fiscal 2025

Simulations Plus, Inc. Releases ADMET Predictor 13

Investor sentiment deteriorates as stock falls 20%

Now 21% undervalued

Simulations Plus, Inc. Releases DILIsym 11

Are Investors Undervaluing Simulations Plus, Inc. (NASDAQ:SLP) By 28%?

Now 28% undervalued after recent price drop

Price target increased by 9.4% to US$46.60

Simulations Plus, Inc. Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Simulations Plus: Benefiting From FDA Modernization And AI

Simulations Plus, Inc.'s (NASDAQ:SLP) 25% Jump Shows Its Popularity With Investors

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Simulations Plus, Inc. Provides Earnings Guidance for the Year 2025

Simulations Plus, Inc. to Report Q2, 2025 Results on Apr 03, 2025

Investor sentiment deteriorates as stock falls 15%

Why Investors Shouldn't Be Surprised By Simulations Plus, Inc.'s (NASDAQ:SLP) 29% Share Price Surge

Now 21% undervalued

Consensus EPS estimates fall by 38%

First quarter 2025 earnings: EPS misses analyst expectations

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Simulations Plus, Inc. Provides Earnings Guidance for the Fiscal 2025

Insufficient new directors

Simulations Plus, Inc., Annual General Meeting, Feb 13, 2025

Simulations Plus, Inc. to Report Q1, 2025 Results on Jan 07, 2025

Investor sentiment improves as stock rises 16%

Simulations Plus, Inc. and University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

We Think Simulations Plus' (NASDAQ:SLP) Healthy Earnings Might Be Conservative

Investor sentiment deteriorates as stock falls 16%

Biosimulation Innovations And Tactical Acquisitions To Boost Drug Development Growth

Price target decreased by 7.5% to US$52.75

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Simulations Plus, Inc. Provides Earnings Guidance for Fiscal Year 2025

Simulations Plus, Inc. to Report Q4, 2024 Results on Oct 23, 2024

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

Simulations Plus, Inc. Announces Executive Changes, Effective August 30, 2024

Simulations Plus: Declining Margins Are A Problem

Now 21% undervalued after recent price drop

Simulations Plus, Inc. Releases the latest version of its quantitative systems toxicology (QST) platform, DILIsym version X

Upcoming dividend of US$0.06 per share

Simulations Plus: Steady Growth, But What About The Margins?

Consensus EPS estimates fall by 14%

Third quarter dividend of US$0.06 announced

Third quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Simulations Plus, Inc. Updates Earnings Guidance for the Fiscal 2024

Now 12% overvalued after recent price rise

Now 21% overvalued after recent price rise

Simulations Plus, Inc. to Report Q3, 2024 Results on Jul 02, 2024

Consensus EPS estimates fall by 17%, revenue upgraded

Price target increased by 12% to US$60.33

Simulations Plus, Inc. (NasdaqGS:SLP) acquired Pro-ficiency, LLC from NovaQuest Capital Management, L.L.C., QHP Capital, L.P. and Pro-ficiency’s minority shareholders for approximately $100 million.